Anti-CD3 monoclonal antibody (Jinan Tiankang Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-CD3 monoclonal antibody (Jinan Tiankang Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionAnti-CD3
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJinan Tiankang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJinan Tiankang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia